Radioimmunotherapy (RIT): Staff, Patient, and Caregiver Educational Considerations Related to Outpatient Administration of Bexxar(r) (Tositumomab and Iodine I-131 Tositumomab), a New Treatment Modality for the Treatment of Non-Hodgkin's Lymphoma (NHL)

2.50
Hdl Handle:
http://hdl.handle.net/10755/165762
Category:
Abstract
Type:
Presentation
Title:
Radioimmunotherapy (RIT): Staff, Patient, and Caregiver Educational Considerations Related to Outpatient Administration of Bexxar(r) (Tositumomab and Iodine I-131 Tositumomab), a New Treatment Modality for the Treatment of Non-Hodgkin's Lymphoma (NHL)
Author(s):
Hendrix, Carolyn
Author Details:
Carolyn Hendrix, Hoag Hospital, Newport Beach, California, USA
Abstract:
Radioimmunotherapy delivered on an outpatient basis presents unique educational considerations for patients, caregivers, and healthcare professionals. Changes in radiation safety guidelines instituted in 1997 by the Nuclear Regulatory Commission (NRC) allow patients treated with radioactive iodine therapies, including RIT, to be treated on an outpatient basis. These regulations include outpatient release (OPR) guidelines. It is important that staff understand the need to implement and maintain radiation safety procedures. Education should include basic radiation safety principles and safety precautions as well as information specific to Bexxar administration and OPR discharge instructions. Three important principles constitute the basics of radiation safety: time, distance, and shielding. Nurses and other healthcare providers need to work efficiently when caring for patients receiving radio-labeled antibodies. Efficiency and minimizing unnecessary exposure are easily achieved with proper training and knowledge of treatment protocols. With training, nurses are able to deliver this therapy under the guidance of a physician licensed to deliver therapeutic isotopes. Because Bexxar is conjugated to I-131, which emits beta and gamma radiation, a room away from general pedestrian traffic is required. Although a special, lead-lined room is not necessary for the delivery of Bexxar at standard doses, the drug treatment set-up used by any given institution must provide adequate shielding. All staff involved in providing patient care are required to wear radiation-monitoring badges. Discharge instructions related to OPR must be followed carefully. Maintaining general and Bexxar-specific precautions are important for patients, caregivers, and healthcare professionals. The development of the RIT team, educational programs, and related tools has been critical to the success of the RIT program at Hoag. In addition to such education, development of the OPR model and collateral tools, including written patient education materials and instructions, have proven key to the on-going success of the RIT program. Conclusion: A treatment program of RIT utilizing Bexxar has been conducted successfully in the Hoag Cancer Center outpatient clinic. Education for all involved (patients, caregivers, and healthcare professionals) has lessened anxieties and misconceptions related to radiation safety. With proper education, the Hoag model has demonstrated that RIT is both feasible and safe on an outpatient basis.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2002
Conference Name:
27th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Washington, D.C., USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleRadioimmunotherapy (RIT): Staff, Patient, and Caregiver Educational Considerations Related to Outpatient Administration of Bexxar(r) (Tositumomab and Iodine I-131 Tositumomab), a New Treatment Modality for the Treatment of Non-Hodgkin's Lymphoma (NHL)en_GB
dc.contributor.authorHendrix, Carolynen_US
dc.author.detailsCarolyn Hendrix, Hoag Hospital, Newport Beach, California, USAen_US
dc.identifier.urihttp://hdl.handle.net/10755/165762-
dc.description.abstractRadioimmunotherapy delivered on an outpatient basis presents unique educational considerations for patients, caregivers, and healthcare professionals. Changes in radiation safety guidelines instituted in 1997 by the Nuclear Regulatory Commission (NRC) allow patients treated with radioactive iodine therapies, including RIT, to be treated on an outpatient basis. These regulations include outpatient release (OPR) guidelines. It is important that staff understand the need to implement and maintain radiation safety procedures. Education should include basic radiation safety principles and safety precautions as well as information specific to Bexxar administration and OPR discharge instructions. Three important principles constitute the basics of radiation safety: time, distance, and shielding. Nurses and other healthcare providers need to work efficiently when caring for patients receiving radio-labeled antibodies. Efficiency and minimizing unnecessary exposure are easily achieved with proper training and knowledge of treatment protocols. With training, nurses are able to deliver this therapy under the guidance of a physician licensed to deliver therapeutic isotopes. Because Bexxar is conjugated to I-131, which emits beta and gamma radiation, a room away from general pedestrian traffic is required. Although a special, lead-lined room is not necessary for the delivery of Bexxar at standard doses, the drug treatment set-up used by any given institution must provide adequate shielding. All staff involved in providing patient care are required to wear radiation-monitoring badges. Discharge instructions related to OPR must be followed carefully. Maintaining general and Bexxar-specific precautions are important for patients, caregivers, and healthcare professionals. The development of the RIT team, educational programs, and related tools has been critical to the success of the RIT program at Hoag. In addition to such education, development of the OPR model and collateral tools, including written patient education materials and instructions, have proven key to the on-going success of the RIT program. Conclusion: A treatment program of RIT utilizing Bexxar has been conducted successfully in the Hoag Cancer Center outpatient clinic. Education for all involved (patients, caregivers, and healthcare professionals) has lessened anxieties and misconceptions related to radiation safety. With proper education, the Hoag model has demonstrated that RIT is both feasible and safe on an outpatient basis.en_GB
dc.date.available2011-10-27T12:24:26Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:24:26Z-
dc.conference.date2002en_US
dc.conference.name27th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationWashington, D.C., USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.